Prognostic Stage III Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Atezolizumab (DB11595)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Recruiting1 IdentifierTitlePurposeDrugs
NCT05092373Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxTreatment